- Home
- XERS vs WLFC Comparison
XERS vs WLFC Comparison
Compare XERS & WLFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- WLFC
- Stock Information
- Founded
- XERS 2005
- WLFC 1985
- Country
- XERS United States
- WLFC United States
- Employees
- XERS N/A
- WLFC N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- WLFC Industrial Specialties
- Sector
- XERS Health Care
- WLFC Consumer Discretionary
- Exchange
- XERS Nasdaq
- WLFC Nasdaq
- Market Cap
- XERS 1.3B
- WLFC 1.0B
- IPO Year
- XERS 2018
- WLFC 1996
- Fundamental
- Price
- XERS $7.64
- WLFC $123.29
- Analyst Decision
- XERS Strong Buy
- WLFC
- Analyst Count
- XERS 7
- WLFC 0
- Target Price
- XERS $9.43
- WLFC N/A
- AVG Volume (30 Days)
- XERS 3.0M
- WLFC 57.2K
- Earning Date
- XERS 11-06-2025
- WLFC 11-04-2025
- Dividend Yield
- XERS N/A
- WLFC 1.30%
- EPS Growth
- XERS N/A
- WLFC 17.99
- EPS
- XERS N/A
- WLFC 16.70
- Revenue
- XERS $266,137,000.00
- WLFC $674,381,000.00
- Revenue This Year
- XERS $43.89
- WLFC $16.17
- Revenue Next Year
- XERS $20.40
- WLFC $4.88
- P/E Ratio
- XERS N/A
- WLFC $7.35
- Revenue Growth
- XERS 42.05
- WLFC 29.58
- 52 Week Low
- XERS $2.82
- WLFC $115.21
- 52 Week High
- XERS $10.08
- WLFC $229.67
- Technical
- Relative Strength Index (RSI)
- XERS 36.31
- WLFC 36.07
- Support Level
- XERS $7.00
- WLFC $115.21
- Resistance Level
- XERS $10.08
- WLFC $123.89
- Average True Range (ATR)
- XERS 0.53
- WLFC 4.89
- MACD
- XERS -0.26
- WLFC -0.42
- Stochastic Oscillator
- XERS 23.38
- WLFC 34.45
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About WLFC Willis Lease Finance Corporation
Willis Lease Finance Corp, with its subsidiaries, is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments, which include Leasing and Related Operations and Spare Parts Sales. A majority of its revenue is generated from the Leasing and Related Operations segment, which involves acquiring and leasing, under operating leases, commercial aircraft, aircraft engines, and other aircraft equipment and the selective purchase and resale of commercial aircraft engines, aircraft equipment, and other related businesses. Geographically, the company derives maximum revenue from the United States, followed by Europe, Asia-Pacific (excluding India), India, South America, Canada, Central America, and the Middle East.